Oral GLP-1 Weight-Loss Medications and Pills
Oral weight-management options have expanded, but tablets differ in active ingredient, administration, absorption, contraindications, evidence, insurance coverage and cost.

Approved oral options
Foundayo
Once-daily oral orforglipron approved for eligible adults; follow its current label.
Wegovy tablets
Oral semaglutide with specific administration instructions.
Other tablets
Contrave, Qsymia, orlistat and traditional prescriptions are not GLP-1 medicines but may suit selected patients.
Do not combine GLP-1 receptor agonists or switch between products without prescriber guidance.
How W8MD can help now
Patients do not need to wait for a future drug to receive evidence-based care. W8MD can compare currently approved weight-loss medications, nutrition, sleep treatment and non-medication plans using medical history, prior attempts, preferences, coverage and sustainable cost.
Discuss currently available options with W8MD
Brooklyn: 718-946-5500 · Northeast Philadelphia: 215-676-2334
Use the form only for a non-urgent callback request. Do not submit private medical, insurance, financial or other sensitive information.
Status reviewed September 4, 2026. Recheck FDA labeling and ClinicalTrials.gov before relying on this page.

